Sort
82,697 grants matching “vaccine development”
Ontogeny &Maintenance of Virus Specific T Cells
$963,735Univ Of Massachusetts Med Sch Worcester · P01 · FY2001 · AI
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
$963,581Alberto Gandini · Accel Diagnostics, Llc · R44 · FY2022 · AI
Administrative Core and Data Management Center
$963,364Henry M Blumberg · Emory University · U19 · FY2017 · AI
Project 4: A permanent off-switch for AAV
$963,326Michael R. Farzan · Scripps Florida · U19 · FY2021 · AI
Task A51: Small Animal Models for Biodefense Viruses
$963,318Connor Idso · Utah State University · N01 · FY2023 · AI
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
$963,221Kathryn M Anastos · Albert Einstein College Of Medicine · U54 · FY2022 · CA
COBRE Center for Molecular and Tumor Virology
$963,192Martin Sapp · Louisiana State Univ Hsc Shreveport · P30 · FY2017 · GM
COBRE Center for Molecular and Tumor Virology
$963,192Dennis John O'Callaghan · Louisiana State Univ Hsc Shreveport · P30 · FY2015 · GM
COBRE Center for Molecular and Tumor Virology
$963,192Dennis John O'Callaghan · Louisiana State Univ Hsc Shreveport · P30 · FY2016 · GM
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
$963,188Lauren Ilyse Richie Ehrlich · University Of Texas At Austin · R01 · FY2020 · AI
Southwest EDRN Clinical Validation Center for Head and Neck Cancer
$963,127Karen Sue Anderson · Arizona State University-Tempe Campus · U01 · FY2024 · CA
Research Project 1: Vaccine for Rapid Response to Filovirus Outbreak
$963,069John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2021 · AI
Task C10: Enhancing Effectiveness of MVA Vector Vaccines
$962,986Peter Silvera · Southern Research Institute · N01 · FY2011 · AI
Pharmacists for Prevention (P4P): Harnessing the role of pharmacists in ending the HIV epidemic through collaboration with pharmacy schools
$962,973Hayden B. Bosworth · Duke University · R01 · FY2025 · AI
Development of CM-SV1, a monoclonal antibody treatment for Sudan Virus
$962,825Paul Guyre · Celdara Medical, Llc · R44 · FY2020 · AI
Immunization against filamentous bacteriophages to prevent bacterial infection
$962,774Jay T. Evans · University Of Montana · R01 · FY2022 · AI
Glycan dependent epitopes of HIV broadly neutralizing antibodies
$962,498James C. Paulson · Scripps Research Institute, The · R01 · FY2018 · AI
Glycan dependent epitopes of HIV broadly neutralizing antibodies
$962,498James C. Paulson · Scripps Research Institute, The · R01 · FY2016 · AI
Glycan dependent epitopes of HIV broadly neutralizing antibodies
$962,498James C. Paulson · Scripps Research Institute, The · R01 · FY2017 · AI
Characterization and improvement of graft versus leukemia effects
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Immunobiology and immunotherapy of leukemia
$962,497Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines
$962,389Nicholas J Mantis · Wadsworth Center · R01 · FY2016 · AI
A Preventative Adenoviral-Based H5N1 Influenza Vaccine
$962,378Andrea Gambotto · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · AI
Designing and optimizing candidate HIV vaccines and boosting protocols
$962,348David Nemazee · Scripps Research Institute, The · R01 · FY2019 · AI
Designing and optimizing candidate HIV vaccines and boosting protocols
$962,348David Nemazee · Scripps Research Institute, The · R01 · FY2021 · AI